Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -106 | -990 | -1,140 | 110 | 130 |
| Depreciation Amortization | N/A | 160 | 200 | 0 | 0 |
| Other Working Capital | 194 | -1,080 | -1,190 | 10 | 70 |
| Other Operating Activity | -141 | 510 | 1,230 | -360 | -240 |
| Operating Cash Flow | $-53 | $-1,400 | $-900 | $-240 | $-40 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -156 | N/A | N/A | N/A | N/A |
| PPE Investments | 35 | -20 | -140 | 0 | 0 |
| Other Investing Activity | 192 | 550 | -3,710 | 30 | -6,320 |
| Investing Cash Flow | $71 | $530 | $-3,850 | $30 | $-6,320 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -35 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | -6 | 5,960 | 0 | 7,050 |
| Financing Cash Flow | $-35 | $-6 | $5,960 | $0 | $7,050 |
| Beginning Cash Position | 408 | 1,280 | 80 | 760 | 70 |
| End Cash Position | 391 | 400 | 1,290 | 540 | 760 |
| Net Cash Flow | $-17 | $-880 | $1,200 | $-210 | $680 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53 | -1,400 | -900 | -240 | -40 |
| Free Cash Flow | -53 | -1,400 | -900 | -240 | -40 |